Starbucks acquisitions are as limited as Omicron dents recovery | Food Issues

Starbucks shares were down 3.5 percent on long-term sales, following a 16 percent decline last month.

Starbucks Corp missed a quarterly market comparison on Tuesday as the rise of COVID-19 in December and new measures hampered recovery in China’s fast-growing Chinese market.

Omicron’s fast-growing change has delayed the reopening of the office and exacerbated the collapse of workers – a chain injury from the United States, which relies heavily on consumers to pick up their coffee on the way to work.

Starbucks shares were down 3.5 percent on long-term sales, following a 16 percent decline last month.

Several Chinese cities have closed their residences and banned travel to reduce COVID-19 before the Winter Olympics, dropping coffee prices. The brand has once again become embroiled in controversy in the country after a report said two of its stores used expired products.

Global equity sales rose 13 percent in the first quarter ending January 2, Starbucks said, while experts surveyed by Refinitiv IBES expect a growth of 13.2 percent.

Similar retail sales in the US exceeded 18 percent, benefiting from soft drinks, higher prices and higher membership rewards.

But sales in the same stores in other countries fell by 3 percent, reflecting a 14 percent decline in China. Researchers were expecting a 0.5 percent increase in the global share.

Rising higher than expected, operating costs and COVID-related costs also hit Starbucks, particularly in December.

Total revenue rose 19 percent to $ 8.1bn, while experts expect $ 7.95bn. In exchange, it earned 72 cents per share.